Literature DB >> 10608750

The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.

I Nordøy1, F Müller, K P Nordal, H Rollag, E Lien, P Aukrust, S S Froland.   

Abstract

The effects of cytomegalovirus (CMV) infection on monocyte and T cell activation and the role of the tumor necrosis factor (TNF) system and interleukin (IL)-10 were studied in a prospective study of 25 renal transplant recipients. Ten patients developed CMV disease (group A), 5 developed asymptomatic infection (group B), and 10 did not have CMV infection (group C). During CMV disease (group A), there was evidence of both monocyte and T cell activation. All patients with CMV infection (groups A and B) showed increased activation of the TNF system, concomitant with an increase in plasma levels of IL-10. Patients with CMV disease (group A) had more marked manifestations of TNF activation and more moderate IL-10 increase than patients with asymptomatic CMV infection (group B), reflected in a higher plasma IL-10/TNF-alpha ratio in asymptomatic patients. Thus, the balance between TNF-alpha and IL-10 may be important in the development of CMV infection and CMV-related disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10608750     DOI: 10.1086/315184

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Authors:  Noelle D Brodeur; Juliet V Spencer
Journal:  Virus Res       Date:  2010-08-20       Impact factor: 3.303

Review 2.  Biomarkers of immune dysfunction in HIV.

Authors:  Daniel E Nixon; Alan L Landay
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

3.  Role of cytomegalovirus on the maturation and function of monocyte derived dendritic cells of liver transplant patients.

Authors:  Mohammad Hossein Karimi; Afsoon Shariat; Ramin Yaghobi; Talat Mokhtariazad; Seyed Mohammad Moazzeni
Journal:  World J Transplant       Date:  2016-06-24

4.  NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain.

Authors:  Mao Li; Srinivasa Rao Boddeda; Bo Chen; Qiang Zeng; Trenton R Schoeb; Victoria M Velazquez; Masako Shimamura
Journal:  Am J Transplant       Date:  2018-05-07       Impact factor: 8.086

5.  Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection.

Authors:  I Nordøy; F Müller; K P Nordal; H Rollag; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

6.  Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.

Authors:  Ajit P Limaye; Corinna La Rosa; Jeff Longmate; Don J Diamond
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

7.  Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation.

Authors:  J Hjelmesaeth; S Sagedal; A Hartmann; H Rollag; T Egeland; M Hagen; K P Nordal; T Jenssen
Journal:  Diabetologia       Date:  2004-08-27       Impact factor: 10.122

8.  Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus.

Authors:  O R Oakley; B A Garvy; S Humphreys; M H Qureshi; C Pomeroy
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

9.  Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages.

Authors:  Daniel L Popkin; Herbert W Virgin
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.

Authors:  Alison J Rodger; Zoe Fox; Jens D Lundgren; Lewis H Kuller; Christoph Boesecke; Daniela Gey; Athanassios Skoutelis; Matthew Bidwell Goetz; Andrew N Phillips
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.